ESC GUIDELINES |
1. | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
PMID: 27305718 doi: 10.1093/eurheartj/ehs104 2012; 40 - 70 3 | Pages 77 - 137
|
|
INVITED REVIEW |
2. | Clinical pharmacology of the apixaban and frequently asked questions about its clinical use Adnan Abacı 2016; 44 - 0 2 | Pages 1 - 6
|
|
3. | Ranolazin: mechanism of antianginal effects Murat Özdemir doi: 10.5543/tkda.2016.72626 2016; 44 - 0 3 | Pages 8 - 12
|
|
EDITORIAL COMMENT |
4. | Reflections from infective endocarditis guideline by European Society of Cardiology; What will change in our practice? Abdullah Doğan PMID: 26717327 doi: 10.5543/tkda.2015.01384 2015; 43 - 8 | Pages 673 - 677
|
|
5. | Acute Pulmonary Embolism Diagnosis and Treatment Guidelines (ESC 2014) Leyla Elif Sade PMID: 25655844 doi: 10.5543/tkda.2015.73780 2015; 43 - 1 | Pages 7 - 11
|
|
ESC GUIDELINES |
6. | 2013 ESH/ESC Guidelines for the management of arterial hypertension
doi: 10.1093/eurheartj/eht151 2014; 42 - 80 4 | Pages 1 - 72
|
|
INVITED REVIEW |
7. | Ischemic stoke in the elderly Birsen İnce PMID: 28976389 doi: 10.5543/tkda.2017.78242 2017; 45 - 90 5 | Pages 83 - 85
|
|
CASE REPORT |
8. | Poster Case Presentations
2013; 41 - 60 2 | Pages 47 - 101
|
|
ESC GUIDELINES |
9. | ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
doi: 10.1093/eurheartj/ehs215 2013; 41 - 70 3 | Pages 1 - 51
|
|
EDITORIAL COMMENT |
10. | Editorial - 2014 European Society of Cardiology Guidelines on Hypertrophic Cardiomyopathy Murat Özdemir PMID: 25620328 doi: 10.5543/tkda.2014.34984 2014; 42 - 8 | Pages 693 - 697
|
|
ORIGINAL ARTICLE |
11. | Herbal supplement usage in cardiac patients Neslihan Pınar, Meyli Topaloğlu, Cahit Özer, Harun Alp PMID: 28990942 doi: 10.5543/tkda.2017.79160 2017; 45 - 7 | Pages 614 - 622
|
|
12. | Methods of risk estimation for cardiovascular disease Hakan Kültürsay doi: 10.5543/tkda.2011.kultursay 2011; 39 - 80 4 | Pages 6 - 13
|
|
REVIEW |
13. | Iron deficiency and anemia in heart failure Yüksel Çavuşoğlu, Hakan Altay, Mustafa Çetiner, Tolga Sinan Güvenç, Ahmet Temizhan, Dilek Ural, Dilek Yeşilbursa, Nesligül Yıldırım, Mehmet Birhan Yılmaz PMID: 28446734 doi: 10.5543/tkda.2017.79584 2017; 45 - 0 2 | Pages 1 - 38
|
|
ESC GUIDELINES |
14. | 2013 ESC guidelines on the management of stable coronary artery disease
doi: 10.1093/eurheartj/eht296 2014; 42 - 80 4 | Pages 73 - 134
|
|
INVITED REVIEW |
15. | 104 Questions about Lipids: Expert Answers Meral Kayıkçıoğlu doi: 10.5543/tkda.2016.77096 2016; 44 - 80 4 | Pages 1 - 141
|
|
ESC GUIDELINES |
16. | ESC Guidelines on the management of cardiovascular diseases during pregnancy
PMID: 27305721 doi: 10.1093/eurheartj/ehr218 2012; 40 - 50 1 | Pages 70 - 120
|
|
INVITED REVIEW |
17. | Clinical studies conducted with new oral anticoagulants in atrial fibrillation: Which oral anticoagulant can be considered for which case in light of the clinical studies? Necla Özer 2016; 44 - 0 2 | Pages 33 - 40
|
|
ESC GUIDELINES |
18. | Guidelines on the management of valvular heart disease (version 2012)
doi: 10.1093/eurheartj/ehs109 2013; 41 - 70 3 | Pages 83 - 128
|
|
EDITORIAL COMMENT |
19. | Comments on 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death Ali Deniz, Mesut Demir PMID: 26875124 doi: 10.5543/tkda.2015.71059 2016; 44 - 1 | Pages 9 - 14
|
|
ESC GUIDELINES |
20. | Third Universal Definition of Myocardial Infarction
doi: 10.1093/eurheartj/ehs184 2013; 41 - 70 3 | Pages 129 - 145
|
|